Extensive resources are required for its implementation, but there is a strong case that bar-code medication-verification technology should be a required practice for demonstrating "meaningful use" of health information technology under the American Recovery and Reinvestment Act.
In reports of industry-funded studies that compared the ocular hypotensive efficacy of topical prostaglandins, conclusions in the article abstracts differed from the results of the main outcome measure 62 percent of the time.